INVIBIO LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -9%

  £46,124,000 → £41,964,000

• Cash

  -68.9%

  £2,233,000 → £694,000

• Net assets

  +48.2%

  £52,431,000 → £77,694,000

• Employees

  0%

  15 → 15

• Operating profit

  +9.9%

  £25,945,000 → £28,515,000

• Profit before tax

  +9.8%

  £25,924,000 → £28,459,000

• Wages

  -4.8%

  £1,333,000 → £1,269,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. INVIBIO LIMITED 2001-03-14 → present
2. INHOCO 2166 LIMITED 2000-10-11 → 2001-03-14

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Following this detailed assessment and taking account of the letter of support received from Victrex plc, the directors are satisfied, that the Company has adequate resources to continue to operate and meet its liabilities as they fall due for the foreseeable future, a period considered to be at least 12 months from the date of signing these financial statements. For this reason, they continue to adopt the going concern basis for preparing the financial statements.”

Group structure

1. INVIBIO LIMITED · parent
   1. Invibio Device Component Manufacturing Limited 100% · United Kingdom · Manufacturer of devices
   2. Juvora Limited 100% · United Kingdom · Active, non trading entity
   3. Invibio Knees Limited 100% · United Kingdom · Producer of medical knee devices and components

Significant events

• “We saw a mixed picture in FY 2025, with lower revenue from Spine (historically our largest market), partially offset by growth in non-Spine revenue.”
• “The Company had net assets of £77,694,000 as at 30 September 2025 (2024: £52,431,000) with the increase driven by higher balances due from fellow group undertakings and no dividend payment was made to the Company's parent entity, Victrex plc, in the year (2024: £39,000,000).”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.